Jim Cramer Regrets Selling Johnson & Johnson Stock Amid Legal Concerns
Jim Cramer sold Johnson & Johnson stock for his Charitable Trust due to talc lawsuit fears but now regrets the decision, citing the company's shift to a pure pharma play and strong drug pipeline.